Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability

Bing Hu; Yuwen Ting; Xiaoqing Yang; Wenping Tang; Xiaoxiong Zeng; Qingrong Huang

doi:10.1039/c2cc17295j

Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability

Bing Hu, Yuwen Ting, Xiaoqing Yang, Wenping Tang, Xiaoxiong Zeng, Qingrong Huang

SEBS - Food Science

Research output: Contribution to journal › Article › peer-review

95 Scopus citations

Abstract

Nanochemoprevention by oral consumption was developed by the encapsulation of (−)-epigallocatechin-3-gallate (EGCG) with nanoparticles that were electrostatically assembled from bioactive caseinophosphopeptides and chitosan, which was highly biocompatible and able to enhance the bioavailability of EGCG.

Original language	English (US)
Pages (from-to)	2421-2423
Number of pages	3
Journal	Chemical Communications
Volume	48
Issue number	18
DOIs	https://doi.org/10.1039/c2cc17295j
State	Published - Feb 1 2012

All Science Journal Classification (ASJC) codes

Catalysis
Electronic, Optical and Magnetic Materials
Ceramics and Composites
Chemistry(all)
Surfaces, Coatings and Films
Metals and Alloys
Materials Chemistry

Access to Document

10.1039/c2cc17295j

Fingerprint Dive into the research topics of 'Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability'. Together they form a unique fingerprint.

Cite this

@article{2eb9bcb0b6c44e03a8d62d230f3b82b4,

title = "Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability",

abstract = "Nanochemoprevention by oral consumption was developed by the encapsulation of (−)-epigallocatechin-3-gallate (EGCG) with nanoparticles that were electrostatically assembled from bioactive caseinophosphopeptides and chitosan, which was highly biocompatible and able to enhance the bioavailability of EGCG.",

author = "Bing Hu and Yuwen Ting and Xiaoqing Yang and Wenping Tang and Xiaoxiong Zeng and Qingrong Huang",

year = "2012",

month = feb,

day = "1",

doi = "10.1039/c2cc17295j",

language = "English (US)",

volume = "48",

pages = "2421--2423",

journal = "Chemical Communications",

issn = "1359-7345",

publisher = "Royal Society of Chemistry",

number = "18",

}

Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. / Hu, Bing; Ting, Yuwen; Yang, Xiaoqing; Tang, Wenping; Zeng, Xiaoxiong; Huang, Qingrong.

In: Chemical Communications, Vol. 48, No. 18, 01.02.2012, p. 2421-2423.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability

AU - Hu, Bing

AU - Ting, Yuwen

AU - Yang, Xiaoqing

AU - Tang, Wenping

AU - Zeng, Xiaoxiong

AU - Huang, Qingrong

PY - 2012/2/1

Y1 - 2012/2/1

N2 - Nanochemoprevention by oral consumption was developed by the encapsulation of (−)-epigallocatechin-3-gallate (EGCG) with nanoparticles that were electrostatically assembled from bioactive caseinophosphopeptides and chitosan, which was highly biocompatible and able to enhance the bioavailability of EGCG.

AB - Nanochemoprevention by oral consumption was developed by the encapsulation of (−)-epigallocatechin-3-gallate (EGCG) with nanoparticles that were electrostatically assembled from bioactive caseinophosphopeptides and chitosan, which was highly biocompatible and able to enhance the bioavailability of EGCG.

UR - http://www.scopus.com/inward/record.url?scp=84863115216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863115216&partnerID=8YFLogxK

U2 - 10.1039/c2cc17295j

DO - 10.1039/c2cc17295j

M3 - Article

C2 - 22266839

AN - SCOPUS:84863115216

VL - 48

SP - 2421

EP - 2423

JO - Chemical Communications

JF - Chemical Communications

SN - 1359-7345

IS - 18

ER -

Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this